Crossmark

Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice

Published Print: 2024-01

Authors

Gratacós-Masmitja, Jordi

Beltrán Catalán, Emma

Álvarez Vega, José Luis

Urruticoechea-Arana, Ana

Fito, Concepción

Maceiras, Francisco

Belzunegui Otano, Joaquín María

Fernández Melón, Julia

Chamizo Carmona, Eugenio

Abad Hernández, Miguel Ángel

Ros Vilamajó, Inmaculada

Castro Oreiro, Sonia

Pascual Alfonso, Eva

Torre Alonso, Juan Carlos
License Information

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2023-10-30
More Information

This article is maintained by: Elsevier

Article Title: Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2023.09.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2023.06.007

Content Type: article

Copyright: © 2023 The Author(s). Published by Elsevier España, S.L.U.

Document is current